We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Scientists Take a Giant Step Closer to Treating Obesity With a Pill

News   Apr 19, 2018 | Original Story from SIMMCAS

 
Neuropeptide Y Y1 Receptor Structure Solved, Offers New Opportunities for Anti-obesity Drug Discovery

Figure: The crystal structure of Y1R binding to an antagonist UR-MK299. The receptor is shown in blue cartoon and surface representations. The antagonist UR-MK299 is shown as grey spheres. Credit: Dr. WU Beili’s group from SIMMCAS

 
 
 

RELATED ARTICLES

Blocking toxic-protein production in ALS

News

An approved drug that blocks an integrated stress response shows promise in preliminary tests against ALS and frontotemporal dementia.

READ MORE

Boy With Rare Brain Tumor One of First in UK to Receive Proton Beam Therapy Treatment

News

A 15-year old from West Sussex, diagnosed with a brain tumor last August, will become one of the first patients in the UK to receive state-of-the-art proton beam therapy treatment at a new £125 million center opened in Manchester.

READ MORE

Can We Restore Memory Function in Alzheimer’s Disease?

News

Research reveals a new approach to Alzheimer's disease (AD) that may eventually make it possible to reverse memory loss, a hallmark of the disease in its late stages.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE